Product Details
Rapid Antibody Test Kit COVID-19 Neutralizing Antibody Rapid test
Kit 20 Tests For Professional Use
Intended Use
- The SARS-COV-2 Neutralizing Antibody Rapid Test Kit is intended for
the semi-quantitative determination of neutralizing antibodies
(NAbs) to SARS-COV-2 that block the interaction between the
receptor binding domain (RBD) of the viral spike glycoprotein with
the ACE2 cell surface receptor in human serum, plasma (EDTA and
sodium citrate), whole blood specimens.
- The test is intended use as an aid in identifying individuals with
an adaptive immune response to SARS-COV-2, indicating recent or
prior infection or assisting in evaluating the effectiveness of the
vaccine clinical trials and mass vaccination.
- Results are for the detection of total neutralizing antibodies to
SARS-COV-2.
Specifications
Test Item | Neutralizing Antibody Test Kit |
Number | LX-401701 |
Sample Volume | Whole blood , Serum, Plasma |
Package | 20 Tests/Kit |
Specificity | 98.00% |
Sensitivity | 97.67% |
Accuracy | >95% |
nspection Method | Immunochromatography |
Shelf Life | 18 Months |
Type | IVD Antibody Rapid Test |
Humidity | 35%-60% |
Main Components
- 20 Test cassettes
- 20 Disposable pipettes
- 20 Sterile Safety Lancets
- 1 Sample Buffer
- 1 Colorimetric chart
- 1 Package Insert
Product Feature
- Accurate: the product has a high accurate serology test for
Neutralizing Antibodies detection
- Easy to administer and read results: no need for instrument or
other equipment during the test
- Fast detection: the result appears in 15 minutes, can be used for
testing on a massive scale.
- No specific storage requirement: room temperature (2-30ºC)
Advantage
- Blood testing, Fingerstick whole blood is workable
- Easy to operate, no additional material required to run the assay
- Little Specimen is required.
Principle
The test employs the sandwich immunoassay to detect the total
neutralizing antibodies. The color intensity of the T line is
correlated with the level of the neutralizing Antibody in specimen.
To determine the level of the neutralizing antibody in specimen,
comparing the intensity of test line to the attached colorimetric
chart.
Use Step
- Place the lanceton the test site.
- Push down the lancet.
- Collect the bloodby transfer pipette.
- Add one drop of blood into the sample well.
- Add 1-2 drops (30-60µL) of sample buffer into the sample well
innediately.
- Wait 15 minutes then read the result.
Interpretation of results
- POSITIVE: The T line and C line are both displayed within the
reaction window, indicates the neutralizing antibodies to
SARS-COV-2 are detected. The result is positive.
- NEGATIVE:The C line is displayed within the reaction window only,
indicates absence of neutralizing antibody to SARS-COV-2.The result
is negative..
- INVALID:1. If the control (C) line is not displayed in 15 min, regardless
of whether T line is present, the test result is invalid. It is
recommended that the specimen should be re-tested.
The test result is invalid after 20 min.
FAQ
We have the MOQ limit,which is 10000 pieces.
After order confirmed,we will arrange your order immediately,and
offer you an
estimated delivery date.
Business to business account.
We choose Air cargo or Ocean cargo.
- Trade Company or Manufacturer:
Manufacturer
Company Profile
Labnovation Technologies, Inc. is an original manufacturer
established in Shenzhen, China since 2001. We are dedicated in
developing and manufacturing IVD instruments and reagents including
HbA1c analyzer and reagents, rapid test reader & reagents,
hematology reagents, clinical chemistry reagents, electrolyte
reagents, wash solution and urine test reagents.
Labnovation products are developed in house, tested extensively in
clinics and passed strict quality controls. All of our products are
CE marked and approved by SFDA. In the past 15 years, our products
have been exported to 110 different countries and used in 8000
hospitals worldwide. We provide both ready-to-use final products
and bulk OEM reagents, including ready-to-use reagents,
concentrated, and powder.
With an investment of 10% of our annual sales into R&D, we
release new products every years. We win more and more domestic and international cooperation by
company reputation and products quality while we actively take part
in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we
are well-known by the companies in this field.